NASDAQ:TRIL did a great job of executing over the past few months in my opinion. It was enough to not only fill the previous gap but also get back to levels it was at prior to the big sell-off. My fear, however, isn't fundamental but more technical as there may be strong resistance at these levels with some "bag holders" seeing it as a potential opportunity to break even? IDK but just speculating here. Either way, it's great to see this is still on the move.
"On Tuesday, the company announced positive interim data on TTI 621. Soon enough the trading volumes on the stock rose significantly. “The program continues to demonstrate clear single agent activity across a range of hematologic malignancies, as well as a strong tolerability profile. We believe that TTI-621, even at these low initial doses, is the only anti-CD47 agent that has shown meaningful single agent activity, including complete responses,” said Dr. Jan Skvarka, President and Chief Executive Officer of Trillium."
SOURCE: 5 Penny Stocks To Watch Before Next Week; 1 Up 720 % Since December
"On Tuesday, the company announced positive interim data on TTI 621. Soon enough the trading volumes on the stock rose significantly. “The program continues to demonstrate clear single agent activity across a range of hematologic malignancies, as well as a strong tolerability profile. We believe that TTI-621, even at these low initial doses, is the only anti-CD47 agent that has shown meaningful single agent activity, including complete responses,” said Dr. Jan Skvarka, President and Chief Executive Officer of Trillium."
SOURCE: 5 Penny Stocks To Watch Before Next Week; 1 Up 720 % Since December